Neurovalens, a 2022 Rosenman Innovator, received FDA 510(k) clearance for their non-invasive device to treat chronic insomnia with electrical pulses. […]
Trouble Sleeping? FDA Clears Medical Device to Treat Insomnia

Neurovalens, a 2022 Rosenman Innovator, received FDA 510(k) clearance for their non-invasive device to treat chronic insomnia with electrical pulses. […]
The specialty care platform built for the tens of millions of women living with hormonal and gynecologic conditions, Allara Health, […]
Midi Health, a 2022 ADAPT finalist, is on a mission to revolutionize midlife care for women, and they’ve just hit […]
Targeted drug delivery technology takes a step forward with Suono Bio’s exclusive patent option agreement for the first-in-kind “RoboCap” electromechanical […]
With little change in the tampon design for nearly a century, an innovative new design may soon hit the shelves. […]
Suono Bio’s ultrasound-mediated drug delivery platform shows promising outcomes in its first-in-human study, demonstrating encouraging results. This is the first […]
Visana Health, a 2021 UCSF Rosenman ADAPT Awardee, secured $10.1 million in seed funding. The funding will allow Visana to […]
Enspectra Health, a 2018 Rosenman Innovator and 2022 UCSF Rosenman RISE company pioneering the virtual biopsy, was awarded a $2M […]
Candesant Biomedical has secured a $35M Series B following FDA clearance for their pioneering anti-sweat patch. This financial boost led […]
Pear Suite, a digital health startup, secures $2.5M in seed funding to boost community health workers’ effectiveness and extend its […]